- Home
- YCBD vs AVGR Comparison
YCBD vs AVGR Comparison
Compare YCBD & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- AVGR
- Stock Information
- Founded
- YCBD 2015
- AVGR 2007
- Country
- YCBD United States
- AVGR United States
- Employees
- YCBD N/A
- AVGR N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- AVGR Medical/Dental Instruments
- Sector
- YCBD Health Care
- AVGR Health Care
- Exchange
- YCBD Nasdaq
- AVGR Nasdaq
- Market Cap
- YCBD 1.8M
- AVGR 2.0M
- IPO Year
- YCBD N/A
- AVGR 2015
- Fundamental
- Price
- YCBD $0.40
- AVGR $0.49
- Analyst Decision
- YCBD
- AVGR Strong Buy
- Analyst Count
- YCBD 0
- AVGR 1
- Target Price
- YCBD N/A
- AVGR $5.00
- AVG Volume (30 Days)
- YCBD 743.5K
- AVGR 194.1K
- Earning Date
- YCBD 02-11-2025
- AVGR 11-07-2024
- Dividend Yield
- YCBD N/A
- AVGR N/A
- EPS Growth
- YCBD N/A
- AVGR N/A
- EPS
- YCBD N/A
- AVGR N/A
- Revenue
- YCBD $20,636,546.00
- AVGR $7,262,000.00
- Revenue This Year
- YCBD N/A
- AVGR N/A
- Revenue Next Year
- YCBD $9.38
- AVGR $93.49
- P/E Ratio
- YCBD N/A
- AVGR N/A
- Revenue Growth
- YCBD N/A
- AVGR N/A
- 52 Week Low
- YCBD $0.31
- AVGR $0.39
- 52 Week High
- YCBD $1.73
- AVGR $5.45
- Technical
- Relative Strength Index (RSI)
- YCBD 42.55
- AVGR 22.72
- Support Level
- YCBD $0.31
- AVGR $0.42
- Resistance Level
- YCBD $0.58
- AVGR $0.73
- Average True Range (ATR)
- YCBD 0.06
- AVGR 0.09
- MACD
- YCBD -0.01
- AVGR -0.03
- Stochastic Oscillator
- YCBD 32.34
- AVGR 21.80
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.